BioDirection inks about $10 mln Series B
BioDirection Inc, a developer of technologies that objective diagnose and manage concussions and other traumatic brain injuries, has closed about $10 million in Series B funding. The investors included Provident Healthcare Capital.
4 February 2016•2 mins read
